Compare Gemini Space Station Inc (GEMI) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs Zoetis Inc — how do they compare? Gemini Space Station Inc trades at $4.05 (market cap $512.05M), while Zoetis Inc trades at $72.68 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 60.8× Gemini Space Station Inc's market cap, and Zoetis Inc pays a 2.81% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals.
| GEMI | ZTS | |
|---|---|---|
Market Cap | $512.05M | $31.14B |
Sector | Technology | Health |
52-Week High | $32.52 | $156.76 |
52-Week Low | $3.90 | $71.91 |
Enterprise Value | $502.04M | $38.70B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GEMI trades at $4.04, down 1.7% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $582.81M in 2025 on revenue of $179.57M, with negative gross and net income margins. Recent news includes a $100M investment from Winklevoss Capital and multiple class-action lawsuits alleging securities law violations.
The outlook remains challenging due to persistent losses and legal overhangs, though analyst consensus suggests a potential upside to $6.33. Key risks include ongoing unprofitability, competitive pressures in financial services, and regulatory scrutiny. Investment opportunity hinges on the company's ability to achieve profitability and navigate legal challenges.
Zoetis (ZTS) trades at $72.42, down 3.27% amid bearish technical signals and recent earnings pressure. The stock shows strong fundamentals with 27.69% net margins and 64.91% ROE, but faces headwinds from softening pet healthcare demand. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a lowered 2026 outlook. Analyst consensus remains positive with a $94.90 price target despite near-term challenges.
The outlook remains cautiously optimistic given ZTS's dominant market position and profitability, though near-term performance depends on reversing companion animal segment weakness. Investment opportunity exists at current discounted valuation (P/E 12.29), balanced against competitive pressures and class action litigation risks. Upside potential aligns with analyst targets if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
